白内障手術機器の世界市場（2023年）：2022年～2028年の分析

当レポートでは、世界の白内障手術機器市場について調査し、市場の概要とともに、白内障発症率と白内障手術に関する動向、今後5年間の市場パフォーマンス予測、重要な将来動向、および市場シェア分析などを提供しています。

目次

• 世界の白内障発症率と白内障手術に関する情報
• 世界の白内障手術件数の現在の推定と5ヶ年予測
• 老眼、屈折異常、屈折レンズ交換術に関する考察
• 米国の白内障および白内障／屈折矯正外科医のプロファイル
• 企業の手術プロバイダーに関する情報
• 現在の診療報酬水準の検討
• フェイコーマシンおよびフェムトセカンドレーザー支援白内障手術装置の説明と考察
• 白内障手術機器メーカーと市場シェアの分析
• フェイコパックとアクセサリーの市場調査
• 光破壊レーザー市場に関する情報

What's New:

The "2023 Cataract Surgical Equipment Market Report" examines the technology destined to shape the future of this market-including Alcon's Unity DFCV, expected to launch in 2023; LENSAR's Ally combination FLACS/ultrasonic phaco system, expected to activate its phaco function in 2024; and Preceyes' robotic cataract system that brings the reality of robotic cataract surgery a step closer.

The 2023 report also provides updates on future trends in cataract surgery, including immediate sequential bilateral cataract surgery and office-based surgery.

The new report focuses on phaco technologies that will help drive conversion from manual surgery-such as the newest fluidic systems to achieve superior chamber stability and safer ultrasonic handpieces. The report also refines the analysis of the phaco machine installed base by country/region by comparing it with the number of OR microscopes.

The 2023 report features an analysis of how individual phaco and FLACS companies market their products by country/region of the world, showing whether a company utilizes a direct sales presence or distributor by country. It also examines the significantly reduced COVID-19 surgical backlog and shows how it will be further reduced over the next five years.

The "2023 Cataract Surgical Equipment Market Report" provides in-depth analysis of the global cataract surgical equipment market, examining the market's size and growth, as well as identifying important developments that may shape its future. The analysis focuses on the 2023 market and forecasts growth and evolution through 2028. Product demand is forecast in units and dollars, and market shares are analyzed by product category. Additionally, 20 competitors are profiled, with discussion of their products, strategic market position, background, and outlook.

Contents:

The "2023 Cataract Surgical Equipment Market Report" includes:

• Information on cataract incidence and cataract surgeries worldwide.

• Current estimates and five-year forecasts for global cataract surgery volume.

• Discussion of presbyopia, refractive errors, and refractive lens exchange procedures.

• Profiles of cataract and cataract/refractive surgeons in the US.

• Information about corporate surgery providers.

• Examination of current reimbursement levels.

• Descriptions and discussion of phaco machines and femtosecond laser-assisted cataract surgery equipment.

• Analysis of cataract surgical device manufacturers and market share.

• Examination of markets for phaco packs and accessories.

• Information on the market for photodisruptor lasers.

Author Profile:

William Freeman

Bill Freeman has more than 35 years of experience developing, manufacturing, and marketing cataract surgery products. He has held key executive positions at four firms that produce ophthalmic surgical devices.

Bill's career in ophthalmology began in the 1970s. As president of Cavitron Surgical Systems, he worked with Dr. Charles Kelman in developing and marketing the world's first phacoemulsifier system. While highly controversial in the 1970s, phacoemulsification gradually became the preferred cataract removal technique in the early 1980s. For many years, Cavitron led the cataract instrumentation market.

CooperVision purchased Cavitron in the early 1980s, and Bill joined the company as president of the surgical division. CooperVision expanded its product line to include a wide variety of cataract surgical products-IOLs, viscoelastic solutions, disposable devices, lasers, and custom packs-and became the market leader in many product categories.

In 1989, Alcon acquired CooperVision in an effort to build a strong presence in cataract surgical devices. Bill joined Alcon as general manager of the Irvine Technology Center, where a number of the company's cataract devices, including the Legacy 20000 phacoemulsifier and a broad line of disposable items, were designed and manufactured.

Bill remained with Alcon until 1995. He then joined Mentor Ophthalmics as president of the ophthalmology division. At Mentor, he was responsible for the company's ophthalmic products including IOLs, cautery devices, and surgical instruments.

After leaving Mentor in 1999, Bill joined Market Scope in 2000 and now serves as executive vice president focusing on ophthalmic surgical cataract, retinal and glaucoma devices.